keyword
https://read.qxmd.com/read/22380933/the-contact-sensitizer-diphenylcyclopropenone-has-adjuvant-properties-in-mice-and-potential-application-in-epicutaneous-immunotherapy
#1
JOURNAL ARTICLE
S von Moos, P Johansen, Y Waeckerle-Men, D Mohanan, G Senti, A Häffner, T M Kündig
BACKGROUND: Epicutaneous vaccination has gained increasing interest during the past decade as it offers a safe, needle-free, and patient-friendly alternative to invasive vaccine administrations. Recently, the safety and early efficacy of epicutaneous immunotherapy were also demonstrated in patients with hay fever, as an alternative to conventional subcutaneous allergen-specific immunotherapy (SCIT). One major challenge to epicutaneous vaccination is the barrier function of the stratum corneum, which must be overcome either by abrasive methods or by hydration...
May 2012: Allergy
https://read.qxmd.com/read/19711024/-targeted-uvb-308-nm-nuvb-therapy-with-excimer-laser-in-the-treatment-of-atopic-dermatitis-and-other-inflammatory-dermatoses
#2
JOURNAL ARTICLE
I Wollenschläger, J Hermann, H M Ockenfels
UVB 311 nm phototherapy (NUVB) is used successfully in the treatment of psoriasis or atopic dermatitis and is often chosen as "first-line" therapy. In a prospective study we investigated the efficacy of the targeted UVB 308 phototherapy by excimer laser in the treatment of 57 patients with localized, mild therapy-resistant atopic dermatitis. We achieved a complete remission (CR) in nearly 85% and a partial remission (PR) in 15% after 10 treatments during 6-8 weeks in all patients. A mean reduction in patient-reported pruritus was one hallmark after 3-4 treatments...
November 2009: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://read.qxmd.com/read/10994256/-chronic-thallium-intoxication-in-five-german-pointers-of-one-litter
#3
JOURNAL ARTICLE
G Gassner, V Tholen, W Ternes
The difficulty of diagnosis and therapy of chronic thallium intoxication is described in five German Pointers with the same skin disease. The detection of thallium in cases of skin lesions like the cutaneous erythema with oedema and crusts or in chronic cases with multifocal alopecia is difficult. The first diagnostic information was gathered in this case from the high thallium level in the urine. The thallium concentration in the hair is subject to great variations, even in physiologic conditions. The trichogramme showed in this case pathognomonic changes like adhesion of the hair follicles...
July 2000: Berliner und Münchener Tierärztliche Wochenschrift
https://read.qxmd.com/read/8767191/-skin-manifestations-in-leishmaniasis-in-dogs
#4
JOURNAL ARTICLE
M Opitz
In 23 dogs with clinically apparent leishmaniosis the observed skin lesions were analyzed with respect to appearance, type and localization. The diagnosis could be established in 22 cases by cytological or histological demonstration of the parasite, positive serodiagnosis and typical clinical findings. The following lesions-in order of frequency-were found on the mucous membranes and the skin including foot pads and nails as well as on the mucocutaneous junctions: 1) desquamation with formation of characteristical light scales, 2) localized or symmetrical alopezia, 3) erythema, 4) ulceration and depigmentation was seen especially at the acrae, 5) granulomatous nodules and pustular dermatitis were less common...
June 1996: Tierärztliche Praxis
https://read.qxmd.com/read/7528962/-dose-intensified-carboplatin-monotherapy-in-advanced-ovarian-cancer
#5
JOURNAL ARTICLE
U Nitz, C Jackisch, W Weise, E Schiller, H J Illiger
Platinum derivatives are known as the most effective cytostatic agents in ovarian carcinoma. The steep dose-response curves described by Hryniuk and Levin [5] make them the ideal substances for dose escalation. We treated patients with advanced ovarian carcinoma with dose intensified carboplatinmonotherapy six times at AUC 5 (= +/- 400 mg/m2 in patients with normal renal function). Dose intensification was not done by increasing single doses, but by shortening the intervals between therapies (23, 21, 17, 14 days)...
1994: Zentralblatt Für Gynäkologie
https://read.qxmd.com/read/2057172/oral-administration-of-idarubicin-as-first-line-cytostatic-therapy-in-patients-with-metastasized-breast-cancer-and-favourable-prognosis-a-trial-of-the-phase-ii-study-group-of-the-association-for-medical-oncology-of-the-german-cancer-society
#6
MULTICENTER STUDY
K Possinger, H Wagner, P Worst, W Queisser, K Bremer, K Rieche, M Klee, M Westerhausen, R Donhuijsen-Ant, D Fritze
Idarubicin is a new anthracycline derivative with therapeutic efficacy in metastatic breast cancer. In a phase II trial we treated 23 patients with advanced breast carcinoma and favourable prognostic factors. Oral dose of idarubicin was 15 mg/m2 day 1-3 repeated every 3 weeks. All patients were pretreated with hormones. Idarubicin was administered as first line chemotherapy. 20 patients were evaluable for response: 3 patients achieved partial remission, 12 patients stable disease; tumour progression occurred in 5 patients...
February 1991: Onkologie
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.